Grants per year
- 250 - 275 out of 378 results
Search results
-
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Huang, W., Batlle, D., Wallia, A. & Molitch, M. E.
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
-
Prot# 20010184: Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT Study)
4/20/05 → 12/17/09
Project: Research project
-
Prot # 808676: The Testosterone Trial
University of Pennsylvania, Solvay Pharmaceuticals, Inc.
5/15/09 → 4/30/10
Project: Research project
-
Prot# ARD-0403-004: A Phase III Open-Label Study of the Efficacy and Safety of ARD-0403, a Testosterone Cream, in Testosterone Deficient Men
7/17/07 → 7/17/10
Project: Research project
-
Prot# B06-29833: Evaluation of Postoperative Glycemic Control on Cardiovascular Surgery Outcomes
6/30/06 → 12/31/07
Project: Research project
-
Prot# B9R-MC-GDGA: The Global Hypopituitary Control and Complications Study (HypoCCS)
8/11/03 → 9/15/13
Project: Research project
-
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Molitch, M. E., Batlle, D. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
-
Prot #C-00044: A Prospective, Randomized, Double-Blind, Sham- Controlled, Multi-Center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita(R) System in Subjects with Type 2 Diabetes on Insulin therapy
Novella Clinical, LLC, Fractyl Laboratories, Inc.
6/29/21 → 6/29/24
Project: Research project
-
Prot # CH-ACM-01: Efficacy and Safety of Oral Octreolin™ in Patients with Acromegaly Who Are Currently Receiving Parenteral Somatostatin Analogs
10/19/11 → 10/19/14
Project: Research project
-
Prot#CIN-107-122 : A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy and Safety of CIN-107 for the Treatment of Patients With Primary ldosteronism (PA)
Medpace Clinical Research LLC, CinCor Pharma, Inc.
2/9/22 → 2/9/25
Project: Research project
-
Prot #CLCI699C2201: A Proof-of Concept, Open-Label, Forced Titration, Multi-Center Study to Assess the Safety/Tolerability and Efficacy of 10-Weeks Treatment of LCI699 Followed by a 12 Week Treatment Period in Patients with Cushing's Disease.
Huang, W., Wallia, A. & Molitch, M. E.
Novartis Pharmaceuticals Corporation
1/1/12 → 10/31/20
Project: Research project
-
Prot#CLCI699C2X01B: An Open-label, Multi-Center, Roll-Over Study to Assess Long Term Safety in Patients with Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-Sponsored Osilodrostat (LCI699) Study and are Judged by the Investigator to Bene
Novartis Pharmaceuticals Corporation
5/22/19 → 12/31/24
Project: Research project
-
Prot#COR-2017-01:A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open-label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Chiltern International, Inc., Cortendo AB (publ)
4/24/18 → 4/24/21
Project: Research project
-
Prot#CORT125134-455: Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant
ICON Clinical Research Limited, Corcept Therapeutics Incorporated
9/25/19 → 9/25/22
Project: Research project